Flurizan, (MPC-7869, (R)-flurbiprofen) a selective A beta-42 lowering agent in patients with mild to moderate Alzheimer's disease: A randomised, placebo-controlled, double blind trial

Autor:	Wilcock, G, Black, S, Haworth, J, Laughlin, M, Hendrix, S, Binger, MH, Zavitz, K, Swabb, E, Hobden, A
Rok vydání:	2016
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2083feee696270c4a895d4d81dcb83fc https://ora.ox.ac.uk/objects/uuid:85be2e46-8486-4264-b9e3-482dfbdd1f18 Zobrazit plný text záznamu